Blueprint Medicines
BPMC
#2500
Rank
HK$40.57 B
Marketcap
HK$634.98
Share price
-6.23%
Change (1 day)
-10.56%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -HK$71.98

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -HK$71.44. In 2022 the company made an earnings per share (EPS) of -HK$72.69 an increase over its 2021 EPS that were of -HK$85.36.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$71.98-0.98%
2022-HK$72.69-14.85%
2021-HK$85.36-297.13%
2020HK$43.30-176.3%
2019-HK$56.7535.19%
2018-HK$41.9838.82%
2017-HK$30.2447.35%
2016-HK$20.529.25%
2015-HK$18.79-31.35%
2014-HK$27.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$0.54-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.10-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.87-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA